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ABSTRACT 
Haemodynamic alterations in carotid and renal arteries are associated with the severity of target organ damage in 
patients with hypertension. Dietary habits, such as the Mediterranean diet, regulate blood pressure and oxidative 
stress, thus reduce the mortality rate due to cardiovascular diseases. In this study, our aim was to evaluate the re-
ducing activity, antioxidant capacity and metal chelating ability of standardized Olea europaea L. leaf extract 
(OLE), and to test its (5, 25, 50 mg/kg) acute in vivo effects, as well as oleuropein’s (OP, 10 mg/kg) on oxidative 
stress, carotid, renal and systemic haemodynamic parameters (blood pressure, heart rate, cardiac output, periph-
eral resistance) in spontaneously hypertensive rats (SHR). OLE has a higher antioxidative capacity than BHT, 
higher reducing ability than vitamin C, and 23 times lower capacity for metal ion chelation than EDTA. All three 
doses of OLE, and OP, improved oxidative stress in SHR. OLE5 improved carotid and renal haemodynamics, 
without significant effects on systemic haemodynamics. Two different mechanisms of antihypertensive respons-
es to OLE were observed, OLE25 was most effective in reducing cardiovascular risks by improving systemic 
and regional (carotid and renal) haemodynamics, peripheral and regional vascular resistance. OLE50 causes the 
improvement of blood pressure and cardiac performances, but tends to retain elevated vascular resistance, there-
fore, reducing  the inflow of blood into the brain and kidneys of the SHR. The OP did not alter systemic or re-
gional haemodynamics, suggesting others constituents responsible for changes of cardiac function, as well as ca-
rotid and renal haemodynamics in response to OLE50. 
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INTRODUCTION 
In the last decades, numerous studies 
have reported many relations between nutri-
tion and health. Dietary habits, such as the 
Mediterranean diet, can be involved in the 
regulation of blood pressure, decrease of ox-
idative stress, improvement of lipid profile 
and reduction of mortality rates due to cardi-
ovascular diseases (Martinez-Gonzalez et al., 
2009). Olea europaea L. is among the inten-
sively studied plants, which is highly repre-
sented in the Mediterranean diet.  
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So far, different experimental models 
have been used with the intention to investi-
gate the hypotensive effect of Olea europaea 
L. leaf extract (OLE). For instance, oral ad-
ministration of OLE showed a dose-
dependent prophylactic effect against the rise 
in blood pressure induced by L-NAME 
(Khayyal et al., 2002). Besides, commercial 
OLE caused a concentration-dependent de-
crease in systolic left ventricular pressure 
and heart rate on isolated rabbit hearts 
(Scheffler et al., 2008). Information is also 
available regarding its activity on experi-
mental models of genetic induced hyperten-
sion after chronic oral administration 
(Romero et al., 2016). The dual effect of 
OLE in both reducing blood pressure and 
improving lipid profile was presented as the 
result of the clinical trials (Perrinjaquet-
Moccetti et al., 2008; Susalit et al., 2011). In 
one word, cardioprotective properties of ol-
ive leaf extract are reflected in its ability to 
reduce blood pressure, exert an antiarrhyth-
mic effect, and preserve coronary blood 
flow. These properties were exercised prob-
ably due to different mechanisms such as the 
blockade of beta receptors (Somova et al., 
2004), angiotensin-converting enzyme 
(ACE) inhibition, Ca2+ antagonism (Susalit 
et al., 2011), as well as vasodilatory NO 
pathways (Miloradović et al., 2013). 
Haemodynamic alterations in carotid and 
renal arteries are associated with the severity 
of target organ (brain, kidney, heart) damage 
in patients with hypertension, and Ohta et al. 
(2008) showed positive correlation between 
carotid vascular resistance and renal vascular 
resistance, indicating that an increase in vas-
cular resistance in those vascular beds may 
develop in parallel. On the other hand, oxi-
dative stress plays a significant role in the 
pathogenesis of cardiovascular disorders, 
and reactive oxygen species (ROS) concen-
tration had been shown to be increased in 
human carotid arteries of older patients, as a 
consequence of excessive production of su-
peroxide ions by NADPH oxidase (Lucas et 
al., 2016). Several animal studies have also 
provided an evidence for increased ROS 
production in the vascular tissue of hyperten-
sive rats, contributing to the generation and 
maintenance of hypertension (Vaziri et al., 
2002).  Recently, we have reported signifi-
cant beneficial effect of different polyphe-
nol-reach plant products on hypertension-
induced alterations of the carotid, but not re-
nal artery haemodynamics (Mihailovic-
Stanojevic et al., 2016a, b), although these 
effects were accompanied by a significant 
reduction of blood pressure and systemic ox-
idative stress. However, to our knowledge, 
there is no information available on the ef-
fects of OLE or its main constituent, oleuro-
pein (OP) on haemodynamics of these two 
different vascular beds. Olive oils have been 
shown to be rich in polyphenols and unsatu-
rated fatty acids that are responsible for the 
enormous antioxidative capacity of this plant 
(Ferrara et al., 2000; Krzeminski et al., 2003; 
Žaneti and Gugi, 2006). In addition, antioxi-
dant properties of the OLE that lead to re-
duction of lipid peroxide accumulation in 
blood and other target organs, have been at-
tributed to the high content of OP and its de-
rivative hydroxytyrosol (Alirezaei et al., 
2012; Suanarunsawat et al., 2011). Beside 
their antioxidative potential, these com-
pounds showed antihypertensive and hypo-
cholesterolemic properties and they have 
been effective in lowering triglycerides as 
well.  
The first aim of the present study was to 
evaluate the reducing activity, antioxidant 
capacity and metal chelating ability of stand-
ardized, OP-rich OLE. The second goal was 
to evaluate the existence of its dose-
dependent influence on systemic and region-
al haemodynamics, as well as the mechanism 
of antihypertensive action in spontaneously 
hypertensive rats (SHR). Lipid profile and 
lipid peroxidation were also investigated in 
this experimental model of essential hyper-
tension. In addition, we compared the ob-
served effects with those caused by OP 
alone.   
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MATERIALS AND METHODS 
Chemicals 
Olive leaf extract EFLA® 943, standard-
ized to 16-24 % of OP, was purchased from 
Frutarom Switzerland Ltd. (Wadenswil, 
Switzerland). The extract was manufactured 
from the dried leaves of Olea europaea L., 
applying an ethanol (80 % m/m) extraction 
procedure. The crude extract was dried after 
a patented filtration process (EFLA® Hyper-
pure). Oleuropein content, stability and mi-
crobiological purity were confirmed by the 
manufacturer. According to the Certificate of 
Analysis provided by Frutarom, the batch 
used in our experiment contained 17 % m/m 
of OP and 40.5 % m/m of total polyphenols. 
Residual solvent ethanol was 0.1 % m/m on-
ly. Oleuropein (purity ≥ 90 %) was obtained 
from Extrasynthese (Geney, France). All 
other reagents were obtained from Sigma-
Aldrich Chemical Co., USA, unless other-
wise stated. 
 
Ferric reducing antioxidant power of OLE 
The antioxidant potential of OLE was de-
termined using ferric reducing antioxidant 
power assay (FRAP) (Benzie and Strain, 
1996). It is based on the change in absorb-
ance at 593 nm as a result of the reduction of 
ferric to ferrous ion and consequent for-
mation of a Fe(II)-tripyridyl triazine.  
 
Trolox Equivalent Antioxidant Capacity of 
OLE 
Another method used for determination 
of antioxidant capacity of OLE was Trolox 
equivalent antioxidant capacity assay 
(TEAC). This assay is based on the ability of 
antioxidants to reduce the ABTS•+, a stable 
radical, formed in the reaction of ABTS 
(2,2’-azinobis (3-ethylbenzothiozoline-6-
sulfonic acid)) and potassium persulfate 
(Krishnaiah et al., 2011). This reduction re-
sults in a decrease in absorbance at 734 nm. 
The assay was done according to a previous-
ly described method (Re et al., 1999).  
 
Metal chelating ability of OLE 
Metal chelating ability was determined 
using a method based on a decrease in ab-
sorbance of Fe(II)-ferrozine complex (Dinis 
et al., 1994). This method was done with 
slight modifications. 450 μL of 1.5 mM 
FeCl2 and 1.8 mL of 385 μM ferrozine were 
added to 50 μL of OLE solution. The mix-
ture was vigorously vortexed and after 10 
min, the absorbance was measured at 562 
nm. All measurements were performed in 
triplicate. EDTA (ethylenediaminetetraacetic 
acid), a potent Fe2+ ion chelator, was used as 
positive control. The result was expressed as 
an EC value (mg/mL, the half maximal ef-
fective concentration of OLE or EDTA). 
 
Animals and experimental protocol 
The experimental protocol was approved 
by the Ethic Committee of the Institute for 
Medical Research, University of Belgrade, 
Serbia (No. 0316-1/11), according to the Na-
tional Law on Animal Welfare ("Službeni 
Glasnik" no. 41/09) that is consistent with 
guidelines for animal research and principles 
of the European Convention for the Protec-
tion of Vertebrate Animals Used for Experi-
mental and Other Purposes (Official Daily 
N. L 358/1-358/6, 18, December 1986) and 
Directive on the protection of animals used 
for scientific purposes (Directive 
2010/63/EU of the European Parliament and 
of the Council, 22.9.2010.). 
We used 24 weeks old male spontane-
ously hypertensive rats (SHR), weighing 
about 300 g, which were bred at the Institute 
for Medical Research, University of Bel-
grade, Serbia. The rats were housed 4 in a 
cage under constant environmental condi-
tions (20-24 °C; 12 h light-dark cycle), and 
fed ad libitum with a standard chow for la-
boratory rats (Veterinarski zavod, Subotica, 
Serbia). 
For the evaluation of dose-dependent ef-
fects of OLE on systemic haemodynamic pa-
rameters before and after treatment, SHR 
were randomly divided into three groups: 
OLE5 (n=7), OLE25 (n=7), OLE50 (n=7) 
which received bolus of OLE 5, 25, and 50 
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mg/kg b.w., dissolved in 0.2 ml saline. The 
highest dose of OLE used in this experiment 
(50 mg/kg) was the same, the highest dose 
used previously in the study in which Zar-
zuelo et al. (1991) were found that the decoc-
tion of olive leaves showed spasmolytic ac-
tivity against phenylephrine-induced con-
tractions in  isolated rat aorta (Zarzuelo et 
al., 1991). The investigated dose of OP, 
10 mg/kg (dissolved in 0.2 ml saline, group 
OP10, n=7) corresponded to its content in 
OLE50 (app 20 % m/m). The control SHR 
group received 0.2 ml saline (n=7).  
Before surgical procedure, all rats were 
weighed and anesthetized with 35 mg/kg of 
sodium pentobarbital.  
 
Systemic haemodynamic measurements  
Systemic haemodynamic parameters 
were measured in anesthetized rats by a di-
rect method. A femoral artery was catheter-
ized with polyethylene tubing (PE–50, Clay-
Adams Parsippany, NY, USA), and connect-
ed to a physiological data acquisition system 
(9800TCR Cardiomax III-TCR, Columbus, 
OH, USA). A jugular vein was cannulated 
with PE-50 for the injection of cold saline. 
The left carotid artery was catheterized with 
PE-50 tubing and attached to a thermo sen-
sor, which was coupled to the Cardiomax III 
for the determination of cardiac output (CO). 
The other end of the thermocouple was 
placed in cold saline. Following 20 min for 
stabilization after surgery, cold saline 
(0.2 ml) was supplied through the jugular 
vein and systolic pressure (SAP), diastolic 
(DAP), mean arterial pressure (MAP), heart 
rate (HR), and CO were recorded before and 
after saline, OLE or OP treatment. Total pe-
ripheral vascular resistance (TPVR) was cal-
culated from MAP and CO and expressed as 
mmHg x min x kg/ml. Pulse pressure (PP) is 
calculated as the difference between the sys-
tolic and diastolic arterial pressure readings 
and it is measured in millimeters of mercury 
(mmHg). 
 
Regional haemodynamic measurements 
For the carotid blood flow (CBF) meas-
urement, the left carotid artery was gently 
separated. An ultrasonic flow probe (1RB, 
internal diameter = 1 mm) was placed 
around the artery and CBF had been regis-
tered using a Transonic T106 Small Animal 
Flowmeter (Transonic System Inc., Ithaca, 
NY, USA). After abdominal incision, left re-
nal artery preparation was utilized and renal 
blood flow (RBF) was recorded. Vascular 
resistance in these two vascular beds – carot-
id and renal arteries (CVR and RVR) was 
calculated by dividing MAP with total blood 
flow through a respective blood vessel, nor-
malized for the body weight and expressed 
as mmHg x min x kg/ml.  
 
Sample collection 
After haemodynamic measurements, 
blood samples were taken by puncture of the 
abdominal aorta into the tubes containing 
lithium-heparin (Li-heparin, Sigma, USA) as 
an anticoagulant and centrifuged at 4000 
rpm, 4 °C for 20 minutes. Plasma samples 
were stored on -20 °C until assayed for lipid 
peroxidation and lipid profile. 
 
Lipid peroxidation 
In order to determine the effects of dif-
ferent OLE doses, as well as OP on the de-
gree of oxidative stress in the circulation, 
plasma lipid peroxide levels were estimated 
by assaying thiobarbituric acid reactive sub-
stances (TBARS) at 540 nm using 2-
thiobarbituric acid (2,6-dihydrooxypyri-
midine-2-thiol; TBA, Acros, Organic). An 
extinction coefficient of 156000 M-1 cm-1 
was used for calculation (Ohkawa et al., 
1979). To evaluate the rate of TBARS re-
leased in vascular beds of interest, carotid 
and renal arteries, plasma TBARS values 
were normalized to respective blood flows 
(CBF and RBF) and expressed as nmol/min/ 
kg b.w. 
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Lipid profile determination 
Total cholesterol, high-density lipopro-
tein cholesterol (HDL-C) and triglyceride 
levels in plasma were measured using an au-
tomatic COBAS INTEGRA 400 plus (Hoff-
mann-La Roche, Germany) analyzer.  
 
Statistical analysis 
The results are shown as the mean with 
the standard error of the mean. We used the 
one-tailed Student's t-test for two-samples of 
equal variance for parameters which were 
analyzed before and after treatment and p < 
0.05 was considered as notable (Microsoft 
Excel 2010). For statistical analysis of other 
parameters one-way analysis of variance 
(ANOVA) was applied. When the ANOVA 
results were significant, LSD (least signifi-
cant difference) was performed as a post hoc 
multiple comparison (Statistics for Win-
dows). P values < 0.05 were considered sig-
nificant. 
 
RESULTS 
In vitro antioxidant capacity assessment  
Estimation of antioxidative potential of 
OLE was made by ferric reducing 
antioxidant power (FRAP method), by 
assessment of free radical scavenging 
activity (TEAC), and metal chelating ability, 
and the results are shown in Table 1. FRAP 
of OLE was 22 times higher compared to 
BHT, and it was almost 50% more effective 
than vitamin C. Similarly, TEAC assay 
showed that the antiradical capacity of OLE 
was 2 times greater than the antiradical 
capacity of BHT, but 4 times lower than the 
antiradical capacity of vitamin C. Metal 
chelating ability of OLE was compared to 
EDTA, and this analysis showed that OLE 
has 23 times lower capacity for metal ion 
chelation than EDTA. 
 
Haemodynamic measurements 
Treatment with 5 mg/kg OLE had no ef-
fect on systemic haemodynamic parameters 
of SHR (Figure 1 and 2). 
 
  
Figure 1: Systolic (SAP), diastolic (DAP) and 
pulse pressure (PP) before and after treatments 
OLE- Olea europaea L. leaf extract, OP- oleuropein, *p < 
0.05, **p < 0.01, ***p < 0.001 the significant difference be-
tween values before and after treatment 
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Table 1: Ferric reducing antioxidant power (FRAP), Trolox equivalent antioxidant capacity (TEAC), 
and the metal chelating ability of Olea europaea L. leaves extract (OLE)  
 FRAP 
mmol Fe2+/g 
TEAC 
mmol TE/g 
Metal chelating ability 
EC50, mg/mL 
OLE 11.858 ± 0.009 1.404 ± 0.023 152.4 ± 0.7 
Vit. C 7.588 ± 0.201 6.002 ± 0.098 / 
BHT 0.472 ± 0.006 0.759 ± 0.010 / 
EDTA / / 6.5 ± 0.2 
EC50, half maximal effective concentration of OLE, EDTA, or vitamin C  
 
 
Figure 2: Mean arterial pressure (MAP), heart rate (HR), cardiac output CO and total peripheral vas-
cular resistance (TPVR) before and after treatments 
OLE- Olea europaea L. leaf extract, OP- oleuropein. *p < 0.05, **p < 0.01, ***p < 0.001 the significant difference between values 
before and after treatment 
 
 
SAP, DAP (Figure 1A, 1B) and MAP 
(Figure 2A) were significantly decreased af-
ter the application of both higher doses of 
OLE, 25 and 50 mg/kg, compared to values 
obtained before treatment. Pulse pressure 
was significantly lower only after treatment 
with a high dose (50 mg/kg) of OLE (Figure 
1C). In OLE50 group, HR and CO were also 
significantly decreased compared to the ini-
tial values (Figure 2B, 2C), while in OLE25 
group significant reduction of TPVR was no-
ticed (Figure 2D). We further examined the 
contribution of OP to the OLE50-induced 
changes of systemic haemodynamic parame-
ters (Figure 3) in SHR. The reduction of 
MAP, HR and CO values that have been ob-
tained in OLE50, were absent in OP10 group 
(Figure 3A, 3B, 3C) while there were no 
differences among TPVR values (Figure 
3D). 
Treatment with 5 mg/kg of OLE slightly 
improved CBF (Figure 4A, p=0.07), and sig-
nificantly decreased CVR compared to the 
control group (Figure 4C, p < 0.05). The 
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dose of 25 mg/kg of OLE significantly 
reduced CVR (p < 0.05), too. Comparison 
between OLE treated groups show that 
OLE5 significantly elevates CBF in relation 
to OLE25 and OLE50 (p < 0.05, and p < 
0.001). An analysis of the effects of OP10 in 
relation to OLE50 and control (Figure 4B, 
4D) has shown that there was no significant 
difference in CBF or CVR between these 
groups, although the decrease of CBF in 
OLE50 was numerically, but not statistically 
different in respect to both, the control and 
OP10 groups (Figure 4B, p=0.09). 
 
Figure 3: Mean arterial pressure (MAP), heart rate (HR), cardiac output (CO) and total peripheral vas-
cular resistance (TPVR) 
OLE- Olea europaea L. leaf extract, OP- oleuropein, *p < 0.05, ***p < 0.001 the significant difference vs.control. #p < 0.05, ###p 
< 0.001 the significant difference vs. OLE50 
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Figure 4: Carotid blood flow and carotid vascular resistance of experimental groups 
OLE- Olea europaea L. leaf extract, OP- oleuropein, *p < 0.05, the significant difference vs.control. ¥p < 0.05, ¥¥p < 0.01, the 
significant difference vs. OLE5 
 
 
Effects of all three doses of OLE on RBF 
and RVR, as well as the comparison of the 
effects of OP10, OLE50 and control values 
of these parameters are presented in Figure 
5. Treatment with the highest dose of OLE 
(50 mg/kg) significantly decreased RBF, 
compared to control group (p<0.05), and 
other OLE treated groups (p<0.01 vs. OLE5, 
p<0.05 vs. OLE25, Figure 5A), as well as 
compared to OP10 (p<0.05, Figure 5B). 
Both, OLE5 and OLE25 significantly re-
duced RVR in comparison to the value no-
ticed in OLE50 (p<0.05, Figure 5C), alt-
hough these reductions did not significantly 
change with respect to the control group. 
RVR obtained for the control, OLE50 and 
OP groups (Figure 5D) showed the highest 
level in OLE50 group, and it was significant-
ly reduced in OP10 group (p<0.05).
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Figure 5: Renal blood flow and renal vascular resistance of experimental groups 
OLE- Olea europaea L. leaf extract, OP- oleuropein, *p < 0.05 the significant difference vs.control. #p < 0.05, ##p < 0.01  the 
significant difference vs. OLE50 
 
 
Lipid peroxidation and lipid profile 
All treated groups showed significantly 
lower levels of plasma TBARS concentra-
tion compared to the control group (OLE5 
and OLE25,  vs. control, p < 0.001, OLE50 
vs. control, p < 0.01, Figure 6A; OP10, vs. 
control, p < 0.001, Figure 6B).  The release of 
TBARS was significantly reduced in both, 
carotid (Figure 6C, 6D) as well as renal 
(Figure 6E, 6F) arteries, in all treated groups 
compared to the control group.  
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Figure 6: Plasma (p) TBARS concentration and the release of TBARS in carotid (c) and renal (r) arter-
ies of experimental groups 
OLE- Olea europaea L. leaf extract, OP- oleuropein, *p < 0.05, **p < 0.01, ***p < 0.001 the significant difference vs.control 
 
 
Lipid profile’s data are shown in Figure 
7. Treatment with all dosages of OLE (Fig-
ure 7A) significantly decreased the values of 
total cholesterol (p < 0.05), but treatment 
with 10 mg/kg of OP showed no effect (Fig-
ure 7B). In comparison with the control 
group, all treatments significantly decreased 
HDL (OLE5, OLE25 and OLE50 vs. control 
p < 0.001, Figure 7C; OP10  vs. control p < 
0.05, Figure 7D) with a considerable de-
crease in the OLE group which received 50 
mg/kg. Moreover, in this group, HDL levels 
were significantly lower than in OLE5, 
OLE25, and OP10 (p < 0.001). 
Groups treated with 5 mg/kg and 25 mg/ 
kg of OLE (Figure 7E), and 10 mg/kg of OP 
(Figure 7F) showed significantly lower level 
of triglycerides in plasma compared to the 
control group (p < 0.001), as well as com-
pared to OLE50 group (p < 0.001). There 
was no difference in triglyceride levels be-
tween the control group and the group treat-
ed with 50 mg/kg of OLE. 
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Figure 7: Lipid profile of experimental groups 
OLE- Olea europaea L. leaf extract, OP- oleuropein, *p < 0.05, **p < 0.01, ***p < 0.001 the significant difference vs. control. 
###p < 0.001 the significant difference vs. OLE50 
 
 
DISCUSSION 
In this study, we showed that OLE has a 
higher antioxidative capacity than BHT, and 
higher reducing ability than vitamin C, a po-
tent natural antioxidant. These data were in 
accordance with previously determined radi-
cal scavenging activity of OLE (Čabarkapa 
et al., 2017), using the 2,2-diphenyl-1-
picrylhydrazyl (DPPH·). Namely, the values 
for the effective concentration (50 % inhibi-
tion) that they obtained indicate a moderate 
antioxidant capacity of the extract 
(Čabarkapa et al., 2017). Furthermore, if we 
compare the  OLE ability to chelate metal 
ions with chelation capacity of other evaluat-
ed natural extracts (Bourgou et al., 2008; 
Ebrahimzadeh et al., 2008; Liu et al., 2008), 
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we assume that this extract can  prevent vas-
cular oxidative stress caused by elevated 
ROS production, thus reduce the cardiovas-
cular risks in SHR. In addition, this effect is 
probably coming from OP (the most abun-
dant phenolic compound in OLE), because 
of its ability to chelate metal ions, such as Cu 
and Fe, which catalyze free radical genera-
tion reactions (Omar, 2010; Suchal et al., 
2016). 
In the second part of the study, we 
showed the existence of two different mech-
anisms of the antihypertensive response to 
OLE in SHR dependent on the dose that was 
applied. Namely, when SHR was adminis-
tered with 25 mg/kg OLE, it affected vascu-
lar mechanisms that regulate the resistance in 
a systemic circulation, resulting in an induc-
tion of significant reduction of TPVR, and 
therefore SAP, DAP, and MAP. Contrary, 
changes involving cardiac mechanisms 
which reflected on HR and CO occurred af-
ter application of OLE in a dose of 
50 mg/kg. The heart rate in OLE50 group 
was significantly reduced, leading to the de-
crease of CO and also to the decrease of 
blood pressure. On the other hand, in OLE25 
group, blood pressure was also decreased, 
but at the expense of significant peripheral 
vasodilation (decreased total peripheral re-
sistance), without altering the CO or HR. 
Previously, we demonstrated that acute oral 
administration of 2 g/kg of OLE reduces 
SAP in SHR (Dekanski et al., 2014), and  
that 30 min duration of antihypertensive ac-
tion of OLE (50 mg/kg) is NO-independent, 
whereby retaining antihypertensive effect 
occurs even after the blocked synthesis of 
NO, indicating that OLE in a dose of 
50 mg/kg achieves blood pressure-lowering 
by mechanisms other than NO (Miloradović 
et al., 2013). The ACE inhibitory activity of 
OLE, concurrent with the calcium channel 
blocking activity, as a result of the synergis-
tic activity of OP and other components of 
OLE, was assumed by Susalit et al. (2011) in 
the clinical study in which the antihyperten-
sive effect of OLE and captopril were com-
pared. However, the study of a cardiotonic 
and antiarrhythmic effects of olive deriva-
tives has shown that the effect of oleanolic 
acid (10 mg/kg) was similar to the effect of 
propranolol, a nonselective beta blocker (2 
mg/kg) (Somova et al., 2004). The fact that 
in our study, blood pressure was normalized 
after the administration of OLE (25 and 50 
mg/kg), but not the OP (10 mg/kg) alone, led 
us to a conclusion that other components 
presented in the extract could be responsible 
for OLE-induced systemic haemodynamic 
alterations, or possibly, the synergism be-
tween the OP and those other components 
are important for such response. Our finding 
that the OP does not contribute to blood 
pressure lowering effect of OLE is in ac-
cordance with previous findings, which 
showed OP (10 and 20 mg/kg during the 3 or 
6 weeks) had no effects on blood pressure in 
rabbits with myocardial infarction (Andrea-
dou et al., 2007), or did not show anti-
arrhythmic effects in isolated rat heart 
(Esmailidehaj et al., 2012).  
Pulse pressure is an independent risk fac-
tor for the development of cardiovascular 
diseases. Previously, it has been shown that 
alpha/beta blocker in combination with 
ACEI reduces the cardiovascular risk due to 
a decrease in pulse pressure (Jovanovic et al., 
2009). The present results also demonstrate a 
significant reduction in pulse pressure in 
SHR after a dose of 50 mg/kg OLE during 
the acute application, which may be ex-
plained by the previously mentioned ACEI 
activity, or the possible beta blockers effects 
of the extract (Susalit et al., 2011). 
Earlier, we showed up to 3 fold higher 
CVR in SHR than in their normotensive 
counterparts, and that this  could be signifi-
cantly improved by acute polyphenol reach 
plant extract treatment (Mihailovic-
Stanojevic et al., 2016a). Here, the lower 
doses of the OLE, 5 and 25 mg/kg, also led 
to a significant reduction of CVR of SHR, 
which in the case of a dose of 25 mg/kg was 
concomitant with a significant decrease of 
MAP. The reduction of CVR was absent af-
ter application of a dose of 50 mg/kg OLE 
and 10 mg/kg OP, further confirming the 
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contribution of vascular mechanisms (in-
volved in the regulation of systemic and re-
gional vascular resistance) in  a fall of blood 
pressure in the group OLE25.  
Haemodynamic changes in the kidney 
have a significant role in the maintenance of 
hypertension. Back in 1986, Ando and co-
workers showed high positive correlation be-
tween renal resistance and MAP in patients 
with essential hypertension. Specifically, the 
treatment with ACEI, captopril, has led to a 
significant decrease in the renal resistance 
and mean arterial blood pressure, while the 
blood flow through the renal artery was 
slightly, but not significantly increased 
(Ando et al., 1986). Our results of renal 
haemodynamics are in accordance with the 
before mentioned, because, the application of 
an OLE, as well as OP, for which it has long 
been established to have ACE inhibitory ac-
tivity (Hansen et al., 1996), had no signifi-
cant effect on blood flow through the renal 
artery. On the other hand, doses of 5 and 25 
mg/kg OLE, and 10 mg/kg of OP lead to a 
reduction in the resistance of the vascular 
bed of hypertensive rats. This decrease in 
RVR in SHR treated with lower doses of 
OLE, together with a statistically significant 
reduction in the CVR, significantly 
contributes to the reduction of TPVR and the 
normalization of blood pressure in our exper-
imental model of essential hypertension. 
In our previous study, we already showed 
that hypertension is followed by increased 
oxidative stress (Miloradović et al., 2013). 
After all OLE treatments (5, 25, and 50 
mg/kg), in the present study, there was a sig-
nificant reduction of plasma lipid peroxida-
tion in SHR, as well as in the group treated 
with 10 mg/kg of OP alone, in comparison to 
the control group. It is well known that OLE 
has potent in vitro (Hayes et al., 2011), as 
well as, in vivo antioxidant activity due to 
the synergy between flavonoids, oleurope-
osides and substituted phenols (El and 
Karakaya, 2009). Since the oxidative stress 
in the circulation of SHR, in our study, 
showed the same trend of decreasing after 
administration of all three doses of OLE, it 
can be assumed that the antioxidant response 
is not dose-dependent, and since it is almost 
the same in the OP group compared to 
OLE50, the OP may be held responsible for 
this effect. In accordance with our results is 
the study of long-term effects of OP which 
shows that OP (oral dose of 15 mg/kg) re-
duces the oxidative stress, the level of 
TBARS, total cholesterol, and triglycerides 
in the model of the ethanol-induced hepato-
toxicity by increasing the activity of antioxi-
dant enzymes (Alirezaei et al., 2012).  
Acute application of OLE in doses of 5, 
25 and 50 mg/kg, led to a reduction in the to-
tal cholesterol level, which points to the hy-
pocholesterolemic effect of OLE. Treatment 
of SHR with 5 and 25 mg/kg of OLE, has led 
to a statistically significant decrease in tri-
glyceride compared to control and OLE50 
group. In rats with streptozotocin-induced 
diabetes (Ghanema and Sadek, 2012), the 
group treated with the OLE showed a reduc-
tion of the level of total cholesterol and 
triglycerides, but also the level of TBARS as 
a result of reduced oxidative stress due to in-
creased concentrations of antioxidative en-
zymes. In our experiment, HDL was also de-
creased by all doses of OLE compared to the 
control group, but most pronounced in the 
group administered with a dose of 50 mg/kg 
of OLE. The triglyceride level was higher in 
this group compared to OP10 group. A sig-
nificant reduction in the level of HDL and 
the increase in levels of triglycerides (Perona 
et al., 2004), has been previously observed in 
elderly hypertensive subjects who used olive 
oil in their diet and were treated with beta-
blockers and diuretics. Given the fact that 
beta blockers tend to increase triglyceride 
levels (direct reduction of their catabolism), 
while reducing the level of HDL (Brook, 
2000), and with our assumption that high 
doses of OLE exhibit their antihypertensive 
and cardioprotective properties, among other 
things, by blockade of the beta-adrenergic 
receptor, it can  be concluded that beta 
blockers characteristic of the components 
present in the 50 mg/kg OLE, different from 
the OP, are responsible for a significant in-
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crease in the concentration of triglycerides 
and the reduction of the amount of HDL in 
our study. However, there are opposing opin-
ions about the effects of olive rich diet on 
high-density lipoproteins (HDL). Some stud-
ies showed that this diet can lead to a de-
crease of HDL due to a higher concentration 
of unsaturated fatty acids, polyphenols, and 
squalen (Mensink and Katan, 1992; Perona 
et al., 2004). On the other hand, a diet rich in 
virgin olive oil can increase plasma HDL 
levels (Rondanelli et al., 2016). In a study 
comparing the effects of olive leaf extract 
(500 mg twice daily during 8 weeks, ~ 12.5 
mg/kg/day) and captopril on blood pressure 
and lipid profile in patients with the stage 1 
hypertension (Susalit et al., 2011), in addi-
tion to the antihypertensive activity, there 
was a significant reduction in total cholester-
ol and triglyceride levels after administration 
of OLE, compared with the group treated 
with captopril, in which there was no change 
of lipid status.  
In conclusion, the lowest used dose of 
OLE, 5 mg/kg, successfully abolished oxida-
tive stress and showed a trend to normalize 
regional (carotid and renal) haemodynamics, 
but was insufficient to reduce blood pres-
sure. Medium dose, 25 mg/kg, was revealed 
as the most effective in reducing cardiovas-
cular risks by improving systemic and re-
gional haemodynamics, oxidative stress and 
lipid profile. Furthermore, the dose of 50 
mg/kg OLE causes the improvement of 
blood pressure, antioxidative defense and 
cardiac performances in such acute study, 
but it tends to retain elevated vascular re-
sistance, therefore reducing the inflow of 
blood into the brain and kidneys of the SHR. 
The main constituent of this standardized ex-
tract, OP alone, failed to ameliorate systemic 
haemodynamics, indicating that other com-
ponents of OLE are responsible for changes 
of cardiac function in SHR. The antioxida-
tive potential, but also the ability of OP to 
improve the lipid profile, unlike the OLE50, 
enables it to act as cardioprotectant. 
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